Latest filing published 25 Feb 2014 for Castle Brands Inc, €95k.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -9.8%Entry US$2.46 · Close at T+365 US$2.22
- +250.0%Entry US$12.50 · Close at T+365 US$43.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Glenn L. Halpryn: trading record in brief
Filings by Glenn L. Halpryn span 6 companies, the busiest being Castle Brands Inc, Niagen Bioscience, Inc. and Fluent, Inc. We count 13 filings; the first trade dates from 29 August 2008 and the latest from 24 February 2014.
On the market, this insider has only ever bought: 3 purchases, €660k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 2 option exercises.
In size, the median ticket on the buying side is €113k. Ninety days after publication, 3 purchases show a median change of +284.0%, with the price up in 67% of them. This is a record of the past, not a forecast.
The newest entry dates from 25 February 2014: an option exercise of €95k, in Castle Brands Inc. The most recent open-market purchase was published on 14 February 2012, 5,381 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Glenn L. Halpryn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 344,066 shares@ US$0.38Common StockSEC:0001209191-14-013733:0
- 850,834 shares@ US$0.304Common StockSEC:0001209191-14-013733:1
- 10,000 shares0Common StockSEC:0001415889-14-000235:0
- 535,714 shares@ US$0.21Common StockSEC:0001415889-13-000242:0
- 200,000 shares@ US$0.75Common StockSEC:0001415889-12-000230:0Canonical exit: 10 May 2012 (T+90)
- 12,688 sharesOrdinary Shares, par value $0.0001 per shareSEC:0001209191-09-052824:0
- 12,688 sharesOrdinary Shares, par value $0.0001 per shareSEC:0001209191-09-050794:0
- 229,000 sharesCommon StockSEC:0001209191-09-045933:0
- 17,184,228 shares@ US$0.0448Common StockSEC:0001209191-09-045270:0Canonical exit: 17 Dec 2009 (T+90)
- 781,102 shares@ US$0.0448Common StockSEC:0001209191-09-045270:1Canonical exit: 17 Dec 2009 (T+90)
- 2,857,144 sharesCommon StockSEC:0001209191-09-010347:0
- 1,833,284 sharesCommon Stock, par value $0.001 per shareSEC:0000938439-08-000010:0
- 533,312 shares@ US$0.22Common Stock, par value $0.001SEC:0000938439-08-000009:0
13 of 13 declarations
